Collins, King Announce $6 Million in EPA Brownfields Grants to Clean Up and Redevelop Contaminated Industrial Sites in Maine

Washington, D.C. — U.S. Senators Susan Collins (R-ME) and Angus King (I-ME) announced today that a total of $6 million in federal brownfields funding has been awarded for the assessment and cleanup of 14 sites in Maine, more funding than any other state in the country this year.  The federal grants awarded by the U.S. Environmental Protection Agency (EPA) will assist local communities as they work to redevelop these contaminated sites in order to improve the environment and promote future economic development.

 

Read More...

Collins, King Join Bipartisan Group in Introducing Legislation to Promote Biomass, Support Maine’s Forest Products Industry

Washington, D.C. — U.S. Senators Susan Collins (R-ME), a member of the Senate Working Forests Caucus, and Angus King (I-ME), a cofounder of the Senate Working Forests Caucus, joined a bipartisan group of Senators in introducing legislation to help expand the use of renewable wood energy.  The bill would allow the use of biomass from certain federal and non-federal lands to promote healthier forests, more carbon sequestration, and cleaner transportation fuels.

 

Read More...

Senator Collins Joins Bipartisan Group in Introducing Adoptee Citizenship Act of 2019

Washington, D.C. – U.S. Senator Susan Collins (R-ME) joined Senators Roy Blunt (R-MO), Mazie Hirono (D-HI), and Amy Klobuchar (D-MN) in introducing the Adoptee Citizenship Act of 2019. The bipartisan bill would close a loophole in the Child Citizenship Act of 2000 (CCA), which has prevented internationally-adopted children, who are now adults, from receiving U.S. citizenship despite being raised by American parents.

 

Read More...

Senators Collins, Scott, Gardner Introduce Legislation to Increase Transparency for Prescription Drug Prices

 

Washington, D.C. — U.S. Senators Susan Collins (R-ME), Rick Scott (R-FL), and Cory Gardner (R-CO) introduced the Prescription Drug Price Reporting Act, legislation that would provide much-needed transparency for prescription drug prices. The bill would create a consumer-friendly database of prescription drug prices, which will empower American families to make informed health care choices.

 

Read More...

Pages